Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
There is a company currently called Agentix that is investigating a new CB1 receptor antagonist as an antiobesity drug and, very unfortunately, its OTC and only has a market cap of 3 million or else this entire article would be about why everyone should short it
The peptide is often sold through unregulated channels as a 'research chemical' or unauthorised medicine, raising significant concerns about purity, dosage accuracy, and contamination
GLP-1 microdosing is gaining attention as more people look for flexible ways to use GLP-1 medications that better fit their bodies, lifestyles, and long-term health goals
In addition to slowing gastric emptying to make you feel full longer
